Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EGFR | P00533 | 15/20 | 0.78 |
| ▸ | KDR | P35968 | 6/20 | 0.73 |
| ▸ | EPHB4 | P54760 | 4/20 | 0.73 |
| ▸ | ERBB2 | P04626 | 3/20 | 0.73 |
| ▸ | AURKA | O14965 | 1/20 | 0.73 |
| ▸ | INSR | P06213 | 1/20 | 0.73 |
| ▸ | FBP1 | P09467 | 1/20 | 0.73 |
| ▸ | PDGFRB | P09619 | 1/20 | 0.73 |
| ▸ | FLT4 | P35916 | 1/20 | 0.73 |
| ▸ | CLK1 | P49759 | 1/20 | 0.73 |
| ▸ | TEK | Q02763 | 1/20 | 0.73 |
| ▸ | AURKB | Q96GD4 | 1/20 | 0.73 |
| ▸ | EPHA2 | P29317 | 3/20 | 0.69 |
| ▸ | FLT1 | P17948 | 1/20 | 0.62 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2286735 | 0.90 | EGFR (0.63) | EGFRKDREPHB4ERBB2AURKA | |
| SCHEMBL666931 | 0.90 | KDR (0.82) | EGFRKDREPHB4ERBB2AURKA | |
| SCHEMBL1446479 | 0.88 | EGFR (0.79) | EGFRKDREPHB4ERBB2AURKA | |
| SCHEMBL29623406 | 0.88 | EGFR (0.79) | EGFRKDREPHB4ERBB2AURKA | |
| SCHEMBL121215 | 0.88 | EGFR (0.79) | EGFRKDREPHB4ERBB2AURKA | |
| SCHEMBL1446018 | 0.88 | EGFR (0.79) | EGFRKDREPHB4ERBB2AURKA | |
| SCHEMBL209526 | 0.88 | EGFR (0.79) | EGFRKDREPHB4ERBB2AURKA | |
| SCHEMBL1331677 | 0.88 | EGFR (0.79) | EGFRKDREPHB4ERBB2AURKA | |
| SCHEMBL209251 | 0.88 | EGFR (0.78) | EGFRKDREPHB4ERBB2AURKA | |
| SCHEMBL185721 | 0.88 | EGFR (1.00) | EGFRKDREPHB4ERBB2AURKA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7998949-B2 | Bicyclic heterocycles, drugs containing said compounds, use thereof, and method for production thereof | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2011-08-16 | — | — | US | disclosed |
| US-7998949-B2 | Bicyclic heterocycles, drugs containing said compounds, use thereof, and method for production thereof | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2011-08-16 | — | — | US | disclosed |
| US-7998949-B2 | Bicyclic heterocycles, drugs containing said compounds, use thereof, and method for production thereof | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2011-08-16 | — | — | US | disclosed |
| US-20100022505-A1 | BICYCLIC HETEROCYCLES, DRUGS CONTAINING SAID COMPOUNDS, USE THEREOF, AND METHOD FOR PRODUCTION THEREOF | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2010-01-28 | — | — | US | disclosed |
| US-20100022505-A1 | BICYCLIC HETEROCYCLES, DRUGS CONTAINING SAID COMPOUNDS, USE THEREOF, AND METHOD FOR PRODUCTION THEREOF | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2010-01-28 | — | — | US | disclosed |
| US-20100022505-A1 | BICYCLIC HETEROCYCLES, DRUGS CONTAINING SAID COMPOUNDS, USE THEREOF, AND METHOD FOR PRODUCTION THEREOF | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2010-01-28 | — | — | US | disclosed |
| WO-2008095847-A1 | BICYCLIC HETEROCYCLES, DRUGS CONTAINING SAID COMPOUNDS, USE THEREOF, AND METHOD FOR PRODUCTION THEREOF | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2008-08-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100022505-A1 | BICYCLIC HETEROCYCLES, DRUGS CONTAINING SAID COMPOUNDS, USE THEREOF, AND METHOD FOR PRODUCTION THEREOF | RET, CYP11B2, CHUK | EGFR 244/4885KDR 896/4885EPHB4 2684/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.